Significance of metabolic and blood pressure factors in relation to microangiopathy and macro angiopathy in patients with non-insulin-dependent diabetes mellitus

Journal of International Medical Research

Volumn 24, Issue 1, 1996, Pages 99-108

  Okada, S ^a   Ichiki, K ^a   Tanokucw, S ^a   Ishii, K ^a   Hamada, H ^a   Ota, Z ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD PRESSURE; DIABETIC MICROANGIOPATHY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLISM; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; SURAL NERVE; SYSTOLIC BLOOD PRESSURE; TIBIAL NERVE; VASCULAR DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; NEURAL CONDUCTION; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0030042089     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/030006059602400113     Document Type: Article

References (28)

1. Diabetes Drafting Group: Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres: The World Health Organisation multinational study of vascular disease in diabetics. Diabetologia 1985; 28: 615-640.
2. Suzuki A: Actual state of diabetic patients with visual disorders - preliminary investigation report. Practice 1989; 6: 434-436.
3. Pettitt DJ, Knowler WC, Lisse JR, et al: Development of retinopathy and proteinuria in relation to plasma-glucose concentrations in Pima Indians. Lancet 1980; ii: 1050-1052.
4. Kalter-Leibovici O, van Dyk DJ, Leibovici L, et al: Risk factors for development of diabetic nephropathy and retinopathy in Jewish IDDM patients. Diabetes 1991; 40: 204-210.
5. Nelson RG, Wolfe JA, Hoton MB: Proliferative retinopathy in NIDDM. Incidence and risk factors in Pima Indians. Diabetes 1989; 38: 435-440.
6. Kannel WB, McGee DL: Diabetes and cardiovascular risk factors; The Framingham Study. Circulation 1979; 59: 8-13.
7. Mattock MB, Keen H, Viverti GC, et al: Coronary heart disease and urinary albumin excretion rate in Type 2 (non-insulin dependent) diabetic patients. Diabetologia 1988; 31: 82-87.
8. Tomono S, Kawazu S: Treatment of diabetic nephropathy -early stage. Diabetes Frontier 1990; 1: 515-524.
9. Seghieri G, Alviggi L, Caselli P, et al: Serum lipids and lipoprotein in type 2 diabetic patients with persistent microalbuminuria. Diabetic Med 1990; 7: 810-814.
10. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 1984; 310: 356-360.
11. Jensen T, Johnsen KB, Enevoldsen AK, et al: Coronary heart disease in young Type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 1987; 30: 144-148.
12. John L, Ganesh A, John G, et al: Nephropathy and non-insulin-dependent diabetes mellitus: comparative study with normoproteinuric and microproteinuric subjects. J Diabetic Compl 1990; 4: 122-125.
13. Who Study Group Diabetes Mellitus: Report of the WHO Expert Committee on Diabetes Mellitus, Report no. 727. WHO Technical Report Series, Geneva, 1985.
14. Aoki K: Study on elastic characteristics of the aorta of living rabbit with special reference to pulse wave velocity and diameter change in situ. J Jpn Coll Angiol 1973; 13: 149-166 (in Japanese).
15. Yoshimura S: A study on arteriosclerosis - Quantitative estimation and pathogenesis of aortic sclerosis by the measuring method of pulse wave velocity. J Jpn Coll Angiol 1978; 18: 863-870 (in Japanese).
16. Okada S, Ichiki K, Tanokuchi S, et al: To what extent does urinary albumin index contribute to estimation of albumin excretion rate in patients with non-insulin-dependent diabetes mellitus? In: Prevention and treatment of NIDDM (Goto Y et al. eds). London: Smith-Gordon, 1992; pp 311-312.
17. Okada S, Ichiki K, Tanokuchi S, et al: The range of urinary albumin index in normoalbuminuria. J Diabetic Compl 1991; 5: 153-154.
18. Okada S, Ichiki K, Tanokuchi S, et al: Determination of a cut off point between treatable and untreatable ranges of nephropathy estimated from the urinary albumin index (UAI) in non-insulin-dependent diabetes mellitus (NIDDM). In: Recent trends of diabetes mellitus in East Asia (Yimura G, Zhisheng C eds). Amsterdam: Elsevier Science Publishers, 1990; pp 239-242.
19. Ferrari-Forcade A, Temesio P, Gomensoro JB: Estudio de la velocidad de conduccion nerviosa en la diabetes. Acta neurol Latinoamer 1960; 6: 43-48 (in Spanish).
20. Mulder DW, Lambert EH, Bastron JA, et al: The neuropathies associated with diabetes mellitus. Neurology 1961; 11: 275-284.
21. Skillman TG, Johnson EW, Hamwi GL: Motor nerve conduction velocity in diabetes mellitus. Diabetes 1961; 10: 46-51.
22. Downie AW, Newell DJ: Sensory nerve conduction in patients with diabetes mel-litus and controls. Neurology 1961; 11: 876-882.
23. Okinaka S: Neuropathy in diabetic patients. J Jpn Diab Soc 1962; 5: 3-22 (in Japanese).
24. DCCT Research Group: Factors in development of diabetic neuropathy: baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). Diabetes 1988; 37: 476-481.
25. Sosenko JM, Gadia MT, Fournier AM, et al: Body stature as a risk factor for diabetic sensory neuropathy. Am J Med 1986; 80: 1031-1034.
26. Robinson LR, Stolov WC, Rubner DE, et al: Height is an independent risk factor for neuropathy in diabetic men. Diabetes Res Clin Prac 1982; 16: 97-102.
27. Dorchy H, Noel P, Kruger M, et al: Peroneal motor nerve conduction velocity in diabetic children and adolescents - Relationships to metabolic control, HLA-DR antigens, retinopathy, and EEG. Eur J Pediatr 1985; 144: 310-315.
28. Diabetes Control and Complications Trial Research. Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 1993; 329: 977-986.